Helius Medical Technologies Files 2025 Proxy Statement
Ticker: HSDT · Form: DEF 14A · Filed: May 2, 2025 · CIK: 1610853
| Field | Detail |
|---|---|
| Company | Helius Medical Technologies, Inc. (HSDT) |
| Form Type | DEF 14A |
| Filed Date | May 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, annual-meeting
Related Tickers: HMTX
TL;DR
Helius Medical (HMTX) filed its 2025 proxy statement. Get ready for the annual meeting.
AI Summary
Helius Medical Technologies, Inc. filed its Definitive Proxy Statement (DEF 14A) on May 2, 2025, for the fiscal year ending December 31, 2024. The filing concerns the company's annual meeting and related corporate governance matters. The company is headquartered in Newtown, PA, and operates in the electromedical and electrotherapeutic apparatus industry.
Why It Matters
This filing provides shareholders with crucial information regarding the company's governance, executive compensation, and proposals to be voted on at the upcoming annual meeting, impacting their investment decisions.
Risk Assessment
Risk Level: low — This is a routine DEF 14A filing, which is standard for public companies and does not inherently indicate new risks.
Key Numbers
- 20250502 — Filing Date (Date the Definitive Proxy Statement was filed with the SEC.)
- 20250523 — Period of Report (The period for which the proxy statement is relevant, typically the upcoming shareholder meeting date.)
Key Players & Entities
- HELIUS MEDICAL TECHNOLOGIES, INC. (company) — Registrant
- 0001104659-25-044128.txt (document) — Filing document name
- 20250502 (date) — Filing date
- Newtown, PA (location) — Company headquarters
- 3845 (industry_code) — Standard Industrial Classification
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose of this DEF 14A filing is to provide shareholders with information for the company's annual meeting, including details on director nominations, executive compensation, and any other proposals requiring shareholder vote.
When was this Definitive Proxy Statement filed with the SEC?
This Definitive Proxy Statement was filed with the SEC on May 2, 2025.
What is the company's Standard Industrial Classification (SIC) code?
The company's SIC code is 3845, which corresponds to Electromedical & Electrotherapeutic Apparatus.
Where is Helius Medical Technologies, Inc. headquartered?
Helius Medical Technologies, Inc. is headquartered at 642 Newtown Yardley Road, Newtown, PA 18940.
What is the fiscal year end for Helius Medical Technologies, Inc.?
The fiscal year end for Helius Medical Technologies, Inc. is December 31.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on May 2, 2025 regarding HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT).